Cited by 93Systemic Sclerosis and Related DiseasesConnective tissue disorders researchPsychosomatic Disorders and Their Treatments

Life with a rare chronic disease: the scleroderma experience

Joachim, Gloria, Acorn, Sonia·2003·Journal of Advanced Nursing

Abstract

Background. Little is known about the experience of living with a rare disease and how people with rare diseases cope with not only the disease but also the reactions of others. Scleroderma is a rare chronic connective tissue disease that results in fibrotic changes involving all or some organs of the body. The two types of scleroderma are systemic scleroderma, which involves the skin and internal organs and is the more serious type, and local scleroderma, which attacks the skin and surrounding tissues. Some people with scleroderma have signs that are visible to outsiders, while others have invisible signs. Having this chronic condition and being different from the general population may subject people with scleroderma to stigmatization by others. Aim. The aim of this study was to understand, from the individual's perspective, the experience of living with scleroderma. Method. Focus group interviews were conducted with two groups of individuals with scleroderma. Because of the rarity of the disease and the illness of the participants, only two groups were held. The same questions were asked of both groups. A moderator and assistant guided the groups. Findings. Data analysis revealed five themes: physical manifestations, disclosure/non‐disclosure to others, living, being normal and facing the future. The data are discussed in light of participants' having visible signs, invisible signs and the rarity of their condition. For those with visible signs, disclosure was automatic. They were conscious of being different from others without scleroderma. Those with invisible signs managed their disease information in such a way as to minimize the stigma of being different. The rarity of the disease added the problem of others not understanding their difficulties. Those who disclosed their disease not only had to deal with the reactions of others, but faced the additional burden of having to explain their condition. Conclusion. Nurses may have little knowledge about scleroderma. It is possible that they, through their ignorance of such rare conditions, may stigmatize individuals. Through understanding about rare diseases will they be able to teach patients the skills necessary to help them cope with their symptoms, as well as the reactions of others to their diagnosis and appearance.

Integrity signals

Registry

Crossref · 10.1046/j.1365-2648.2003.02663.x

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The quality of life of patients with ROD is lower than for the general population in three key areas: physical limitations, social isolation and stigmatization, and emotional distress.

    “The quality of life of patients with ROD is lower than for the general population in three key areas: physical limitations (movements, pain, sleep problems, attention or concentration problems that affect daily life), [3–9], social isolation and stigmatization [3, 7, 9–13], and emotional distress (anger, depression, anxiety, hopelessness, loss, lack of control, abandonment) [3, 5, 8, 14–17].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Joachim, G., & Acorn, S.
Affiliations
University of British Columbia (CA)
Venue
Journal of Advanced Nursing
Publisher
Wiley
Published
2003-06
Volume
42
Issue
6
Pages
598-606
ISSN
  • 0309-2402 (ISSN-L)
  • 1365-2648
OpenAlex
W2065003249
Cited by
93
References
37
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 7 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 10 · 2018: 9 · 2017: 11 · 2016: 6 · 2015: 3 · 2014: 7 · 2013: 6 · 2012: 3
FWCI
0.18
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Advanced Nursing (publishedVersion)
  • PubMed (publishedVersion)
Funders
Scleroderma Association of British Columbia
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Systemic Sclerosis and Related Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
Keywords
systemic sclerosis, rare diseases, lived experience, chronic disease, stigma, disclosure of illness, coping
MeSH terms
Adaptation, Psychological, Chronic Disease, Female, Humans, Middle Aged, Scleroderma, Localized, Scleroderma, Systemic, Stereotyping, Focus Groups, Rare Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review